Key result
A blocking ELISA with a baculovirus-expressed structural protein exhibited 99% specificity and sensitivity comparable to standard assays for detecting foot-and-mouth disease virus type A antibodies.
A novel blocking ELISA using a baculovirus-expressed structural protein shows high specificity and comparable sensitivity to standard tests for detecting foot-and-mouth disease virus type A antibodies.
May support evaluation of baculovirus ELISA as a specific FMDV diagnostic; leaves open routine adoption pending further validation.
A blocking enzyme-linked immunosorbent assay (ELISA) with a baculovirus-expressed structural protein was developed for the detection of antibodies to foot-and-mouth disease virus type A. It exhibited 99% specificity with a cutoff of 53% inhibition. Its sensitivity was comparable to the sensitivities of the virus neutralization test and the liquid-phase blocking ELISA, indicating its potential as an alternative assay.
No takes yet. Share an insight, caveat, or question.
Ko et al. (2009) studied Foot-and-mouth disease virus type A antibodies. Blocking ELISA with a baculovirus-expressed structural protein vs. Virus neutralization test and liquid-phase blocking ELISA was evaluated on Specificity and sensitivity for detection of antibodies. A blocking ELISA with a baculovirus-expressed structural protein exhibited 99% specificity and sensitivity comparable to standard assays for detecting foot-and-mouth disease virus type A antibodies.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: